Organization

Organovo Holdings, Inc.

About

Organovo is an early stage biotechnology company with a focus on building high fidelity, 3D tissues that epitomize key aspects of human disease. Using these models to identify gene targets that are responsible for disease growth, Organovo plans to initiate drug discovery programs around those validated targets. Their initial focus is on the intestines and currently have ongoing development efforts in ulcerative colitis (“UC”) and Crohn’s disease (“CD”) for 3D tissues. The company's proprietary technology mirrors key aspects of human tissue composition, structure, functionality and disease. Some key advancements so far by Organovo include cell type-specific compartments, prevalent intercellular tight junctions, and the formation of microvascular structures.

Overview

Founded 2007
Type Public
Location San Diego, California, USA

Stock

ONVO $0.00 0.00% $0.00

Latest News

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket Sep 22, 2022 Benzinga Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset,...
Why Applied Optoelectronics Is Trading Higher By Around 31%; Here Are 21 Stocks Moving Premarket Sep 16, 2022 Benzinga Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) rose 159.4% to $25.94 in pre-market trading after gaining 11% on Thursday. Applied Optoelectronics, Inc. (NASDAQ: AAOI)...
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday Sep 07, 2022 Benzinga Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility. IVERIC bio, Inc. (NASDAQ: ISEE) rose...
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session Sep 06, 2022 Benzinga Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a...
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference Sep 06, 2022 GlobeNewswire Inc. SAN DIEGO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO), an early-stage biotechnology company that is focusing on building high fidelity, 3D...